The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 · Blood · 7,721 citations
https://doi.org/10.1182/blood-2016-01-643569
A
Andrew D. Zelenetz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
757
Papers
42.7K
Citations
96
h-index
318
i10-index
Andrew D. Zelenetz is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Viral-associated cancers and disorders. The author has an h-index of 96, co-authored 644 publications.
ORCID: 0000-0003-1403-6883Papers by this author
worksThe International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
2022 · Blood · 1,387 citations
https://doi.org/10.1182/blood.2022015851
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
2013 · Blood · 934 citations
https://doi.org/10.1182/blood-2013-09-524108
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
2014 · Blood · 461 citations
https://doi.org/10.1182/blood-2014-05-578963
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
2017 · The Lancet Oncology · 247 citations
https://doi.org/10.1016/s1470-2045(16)30671-4
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
2013 · Nature Genetics · 207 citations
https://doi.org/10.1038/ng.2652
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat